NASDAQ:BLGO BioLargo (BLGO) Stock Price, News & Analysis $0.25 -0.02 (-6.93%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock About BioLargo Stock (NASDAQ:BLGO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioLargo alerts:Sign Up Key Stats Today's Range$0.25▼$0.2750-Day Range$0.24▼$0.2952-Week Range$0.16▼$0.37Volume344,050 shsAverage Volume254,350 shsMarket Capitalization$75.73 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.Read More… Remove Ads Receive BLGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLargo and its competitors with MarketBeat's FREE daily newsletter. Email Address BLGO Stock News HeadlinesEarnings call transcript: BioLargo Q1 2025 reveals strong revenue growthApril 2 at 12:40 PM | investing.comBioLargo, Inc. (PNK:BLGO) Q4 2024 Earnings Call TranscriptApril 2 at 8:49 AM | insidermonkey.comTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.April 4, 2025 | Porter & Company (Ad)BioLargo Reports Record Revenue Growth in 2024April 2 at 12:11 AM | tipranks.comBioLargo to Present at the AI & Technology Virtual Investor Conference April 3, 2025April 1 at 9:00 AM | financialpost.comBioLargo to Present at the AI & Technology Virtual Investor Conference April 3, 2025April 1 at 8:35 AM | globenewswire.comBioLargo, Inc. (BLGO) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comBioLargo Presents at Webcast Investor ConferenceMarch 31, 2025 | tipranks.comSee More Headlines BLGO Stock Analysis - Frequently Asked Questions How have BLGO shares performed this year? BioLargo's stock was trading at $0.19 at the beginning of the year. Since then, BLGO shares have increased by 32.3% and is now trading at $0.2513. View the best growth stocks for 2025 here. How do I buy shares of BioLargo? Shares of BLGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioLargo own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioLargo investors own include Hydrofarm Holdings Group (HYFM), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Meta Platforms (META), Micron Technology (MU), Petróleo Brasileiro S.A. - Petrobras (PBR) and Clean Energy Fuels (CLNE). Company Calendar Today4/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConstruction Industry Chemicals & allied products Sub-IndustryChemicals Current SymbolNASDAQ:BLGO CIK880242 Webwww.biolargo.com Phone(888) 400-2863Fax949-625-9819Employees30Year Founded1989Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,500,000.00 Net Margins-11.45% Pretax Margin-19.65% Return on Equity-39.90% Return on Assets-22.06% Debt Debt-to-Equity Ratio0.03 Current Ratio2.31 Quick Ratio2.24 Sales & Book Value Annual Sales$12.23 million Price / Sales6.35 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book25.78Miscellaneous Outstanding Shares301,368,000Free Float240,168,000Market Cap$77.69 million OptionableNot Optionable Beta-0.02 Social Links 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?Get This Free Report This page (NASDAQ:BLGO) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLargo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.